ClinicalTrials.gg
CompletedNCT06134518Updated Sep 19, 2024

Effectiveness of the Education Program on Increasing the Competency Level of Health Cadres in Indonesia

An interventional study of The education program and the initial orientation from the PHCs in Maternal Mortality, sponsored by Hiroshima University. Completed at 1 site in Indonesia. Open to female participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Hiroshima University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
133
Allocation
Non-randomized
Ages
19 Years and older
Sex
Female
01

Study summary

Ending preventable maternal mortality (EPMM): By 2030, every country should reduce its maternal mortality ratio (MMR) by at least two-thirds from the 2010 baseline. In the era of the SDGs, an acceleration of current progress is required to achieve SGD target 3.1, working towards a vision of ending all preventable maternal mortality. In Central Java, one of the most effective efforts to reduce maternal mortality is increasing the number of human resources, who can assist pregnant mothers and supervise their period of pregnancy. The maternal mortality rate (MMR) in Banjarnegara Regency in 2021 is 287.05 per 100,000 live births, this indicates the top 10 in Central Java Province over the past 5 years. Health cadres, who are non-professional volunteer health supporters for pregnant women appointed by regional public health centers (PHCs), are expected to be the key human resources who contribute to reducing MMR in Indonesia and Banjarnegara Regency as well. However, based on an initial study by researchers conducting qualitative research with focus group discussions (FGDs) and in-depth interviews in April-July 2023, researchers found that health cadres had incorrect and unscientific knowledge. Therefore, improving the knowledge and skills of the health cadres through education programs could be expected to further improve the health outcomes of pregnant women, consequently contributing to reducing the MMR.

The purpose of this study is to improve health cadres' competency level in monitoring the risks of pregnant women. This monitoring activities for pregnant women by cadres is an effort to prevent maternal mortality, because if there are complications they can be treated as early as possible.

Read the detailed description
  1. Prior to the commencement of the study, the PI will visit the selected PHCs as the intervention group and control group, and then explain an overview of this study. The PI obtained the agreement to participate in this study from the head of the PHC.
  2. The PI will ask the coordinator midwife at each PHC to introduce the names and phone numbers of the health cadres who will be potential participants. The PI and the researchers will contact each potential participant one by one to explain the procedure of this study and then obtain their consent to become a participant in this study. Cadres who belong to PHCs will receive the competency-based education program, and those who belong to PHCs allocated to the control group will follow the initial orientation provided by the PHC.
  3. The PI and assistant (research team) will create a WhatsApp group for the intervention group and control group, and then distribute the questionnaires at an initial stage. All data will be collected at each PHC where the study will be conducted.
02

Conditions studied

  • Maternal Mortality

Browse trials for

Keywords

  • competency level, health cadre, maternal mortality
03

In context

Maternal Death

77 studies on the registry are indexed under Maternal Death; 19 are open to participants now.

This study's enrollment of 133 is below the median of 1,126 across 57 interventional studies indexed under Maternal Death.

Browse Maternal Death studies →

Lead sponsor

Hiroshima University is the lead sponsor of 45 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Currently working as a health care for at least 1 year
  2. Domiciled in the local area
  3. Able to operate a telephone
  4. Those who agreed to give consent and are willing to participate in the study
  5. Those who agreed to receive the health education program and participate in the whole evaluation process.

Exclusion criteria

Exclusion Criteria:

  1. Those who are planning to move out to another city during the study period.
  2. Those who are no longer work as a health cadre.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
133 participants (actual)

Study arms

  • Experimental
    intervention

    The intervention group will receive the competency-based education program for 1 month at each PHC, after baseline data collection. The education program will be conducted weekly. This education session will be conducted for 4 hours per session, with 20 health cadres in a group per PHC .The competency level is measured by the researcher developing a competency questionnaire which consists of a knowledge test, skill, and attitude checklist score at the 2nd post-assessment (2 months after being given the education program).

    Other: The education program

  • Experimental
    control

    Health cadres in the control group have received the initial orientation from the PHCs. In this study, they take only the competency questionnaires including skill check will be collected following the data collection timeline. After completing the research, the control group will receive the education program material used for the intervention group if they require.

    Other: the initial orientation from the PHCs

Interventions

  • OtherThe education program

    The intervention group will receive the competency-based education program for 1 month at each PHC, after baseline data collection. The education program will be conducted weekly. This education session will be conducted for 4 hours per session, with 20 health cadres in a group per PHC. The competency level is measured by the researcher developing a competency questionnaire which consists of a knowledge test, skill, and attitude checklist score at the 2nd post-assessment (2 months after being given the education program).

  • Otherthe initial orientation from the PHCs

    the initial orientation from the PHCs

06

What researchers measure

Primary outcomes

  1. The competency level of health cadres

    Competency is operationally defined as the ability to integrate components of knowledge, skills, values, and attitudes into practice, and build a trusting relationship with and guide a pregnant woman and her surroundings for them to take evidence-based appropriate behavior. The competency level is measured by the researcher developing a competency questionnaire which consists of a knowledge test, skill, and attitude checklist score

    Time frame: baseline (T0), after 1 month from the baseline (T1) and after 3 months from the baseline (T2)

Secondary outcomes

  1. The knowledge test scores of health cadres

    researcher developing knowledge questionnaire

    Time frame: baseline (T0), after 1 month from the baseline (T1) and after 3 months from the baseline (T2)

  2. The health assessment skills checklist score of health cadres

    researcher developing health assessment skills checklist

    Time frame: after 1 month from the baseline (T1) and after 3 months from the baseline (T2)

  3. The communication skills checklist score of health cadres

    researcher developing communication skills checklist

    Time frame: after 1 month from the baseline (T1) and after 3 months from the baseline (T2)

  4. The confidence score of health cadres

    researcher developing communication skills checklist

    Time frame: after 1 month from the baseline (T1) and after 3 months from the baseline (T2)

  5. The satisfaction score of health cadres

    researcher developing satisfaction skills checklist

    Time frame: after 1 month from the baseline (T1)

07

Study locations

1 site
  • Politeknik Banjarnegara
    Banjarnegara, Cental Java 53482, Indonesia
08

References and documents

Individual participant data

Plan to share: Yes — Share according to request to the PI and researcher

Time frame: April 2025 - April 2026

Access criteria: dewiesulistyorini@gmail.com

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2023 to primary completion in Dec 2023, 0 months.

Of 35 interventional studies with no phase under Maternal Death, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 41. This study's 0 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2023
First posted
Nov 18, 2023
StartActual
Nov 30, 2023
Primary completionActual
Dec 5, 2023
CompletionActual
Feb 17, 2024
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06134518
Lead sponsor
Hiroshima University
Responsible party
Dewie Sulistyorini (Principal Investigator, Hiroshima University) — Principal investigator
First posted
Nov 18, 2023
Start date
Nov 30, 2023
Primary completion
Dec 5, 2023
Completion
Feb 17, 2024
Last update
Sep 19, 2024

Study contacts

Dewie Sulistyorini
principal investigator · Hiroshima University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion